|
|
|
|
 DEVELOPMENT OF CHINA'S INDUSTRY |
| Year 2006 was predestined to be an extraordinary one to the pharmaceutical industry development. During this year, the industry managed to suffer due to a series of reform policies including reduction in prices of drugs, regulation of commercial bribes, rectification and regulation of drug market order. |
| |
|
| STATUS OF FOREIGN INVESTMENT |
| According to the statistics released by Ministry of Commerce, in 2006 there were 405 projects using foreign investment in pharmaceutical industry, down 11.96% under the same period of the previous year. The actually used foreign capital amount was 520 million USD, down 7.1% under the previous year. |
|
|
|
| COMMITMENTS TO THE WTO AND INTERNATIONAL PRACTICES |
| According to Annex II, Staging Matrix for Section II (Other Products' Concessions), the mentioned pharmaceutical products are as follows (tariff lines, product's name, bound rate at the day of accession, final bound rate, implementation year, referring to 1 January of the year indicated when the final bound rate will be achieved) |
|
|
|
| DEVELOPMENT OF GLOBAL INDUSTRIES |
| In 2006, global pharmaceuticals market sale made new high record, rising 7.0% to 643 billion US dollars. It was said that in the data collection market of IMS, the pharmaceuticals sale totaled up to 607.9 billion US dollars with 6.5% year-on-year increase. |
|
|
|
 |
|
|
